UBS Reports 4.62% Interest in QIAGEN
UBS Group AG reported a 4.62% capital interest and voting-rights holding in QIAGEN as of November 5, 2026, comprising 2.11% real and 2.51% potential holdings.
UBS Group AG reported a 4.62% capital interest and voting-rights holding in QIAGEN as of November 5, 2026, comprising 2.11% real and 2.51% potential holdings.